-
Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories
prnasia
July 06, 2021
Everest Medicines announced that Spero Therapeutics, Inc., entered into a regional licensing agreement with Pfizer Inc. for SPR206.
-
Ministry data said to show Pfizer shot blocks majority of serious Delta cases
firstwordpharma
July 06, 2021
A study from researchers at Hebrew University and Hadassah University Medical Center suggest Pfizer and BioNTech's COVID-19 vaccine is 60% to 80% effective against infection from the Delta variant, reported The Times of Israel.
-
Israel says negotiating Pfizer surplus with other countries
firstwordpharma
July 05, 2021
Israel is in talks with other countries about a deal to unload its surplus of Pfizer/BioNtech COVID-19 vaccines, officials said on Sunday, as reported by This is Money.
-
‘Mix and match’ COVID-19 vaccine study yields promising results
pharmatimes
June 30, 2021
A study evaluating a mix and match approach to COVID-19 vaccinations has found that using a different jab for the first and second doses gives good protection against the virus.
-
Pfizer says COVID vaccine is highly effective against Delta variant
expresspharma
June 28, 2021
First identified in India, Delta is becoming the globally dominant variant of the coronavirus, according to the World Health Organization.
-
Pfizer halts distribution of anti-smoking drug after finding carcinogen
expresspharma
June 28, 2021
The US drug regulator has, in the past, reached out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels.
-
Global API market to value $300 billion by 2030
europeanpharmaceuticalreview
June 25, 2021
Researchers anticipate the growth of the aging population and rising investment in biologic drugs to promote the expansion of the global active pharmaceutical ingredient (API) market.
-
GSK to boost growth with Consumer Healthcare business spin-off
pharmaceutical-technology
June 25, 2021
GlaxoSmithKline (GSK) has plans to spin off its consumer healthcare unit into a separate company while the resultant New GSK will focus on developing vaccines and speciality drugs.
-
Coronavirus Delta Variant Spreading Rapidly in the United States
drugs
June 24, 2021
The delta variant of the coronavirus that once crippled India now accounts for 20 percent of infections in the United States, Anthony Fauci, M.D., director of the U.S. National Institute of Allergy and Infectious Diseases, said Tuesday.
-
FDA to add warning about rare heart inflammation to Pfizer, Moderna vaccines
firstwordpharma
June 24, 2021
The FDA will add a warning about rare cases of heart inflammation in adolescents and young adults to fact sheets for the Pfizer/BioNTech and Moderna COVID-19 vaccines, as reported by the National Post.